María Concepción Prados Sánchez-rekin lankidetzan egindako argitalpenak (9)

2023

  1. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

2022

  1. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

    Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231

  2. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

2016

  1. Depression and anxiety symptoms in Spanish adult patients with cystic fibrosis: Associations with health-related quality of life

    General Hospital Psychiatry, Vol. 40, pp. 39-46

2001

  1. Guidelines for diagnosing and treating respiratory involvement in cystic fibrosis

    Archivos de Bronconeumologia, Vol. 37, Núm. 8, pp. 316-324

  2. Nebulized antibiotics patients with cystic fibrosis

    Medicina Clinica

2000

  1. Fibrosis quística: Consenso sobre el tratamiento del neumotórax y de la hemoptisis masiva y sobre las indicaciones del trasplante pulmonar

    Archivos de Bronconeumologia, Vol. 36, Núm. 7, pp. 411-416